Fig. 1From: Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19?Ordinal Scale for Clinical Improvement (WHO R&D Blueprint) [1]Back to article page